Essent Group (ESNT): Buy, Sell, or Hold Post Q1 Earnings?
Is now the time to buy Essent Group, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it's free.
Why Is Essent Group Not Exciting?
We're swiping left on Essent Group for now. Here are three reasons why you should be careful with ESNT and a stock we'd rather own.
1. Net Premiums Earned Points to Soft Demand
While insurers generate revenue from multiple sources, investors view net premiums earned as the cornerstone - its direct link to core operations stands in sharp contrast to the unpredictability of investment returns and fees.
Essent Group's net premiums earned has grown at a 4.2% annualized rate over the last five years, worse than the broader insurance industry and slower than its total revenue.
2. Deteriorating Pre-tax Profit Margin
Revenue growth is one major determinant of business quality, and the efficiency of operations is another. For insurance companies, we look at pre-tax profit rather than the operating margin that defines sectors such as consumer, tech, and industrials.
Insurance companies are balance sheet businesses, where assets and liabilities define the economics. Interest income and expense should therefore be factored into the definition of profit but taxes - which are largely out of a company's control - should not. This is pre-tax profit by definition.
Over the last four years, Essent Group's pre-tax profit margin has risen by 17.7 percentage points, clocking in at 67.2% for the past 12 months. Said differently, the company's expenses have grown at a slower rate than revenue, which is always a positive sign.
3. EPS Barely Growing
Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.
Essent Group's EPS grew at a weak 1.9% compounded annual growth rate over the last five years, lower than its 7.1% annualized revenue growth. This tells us the company became less profitable on a per-share basis as it expanded.
Final Judgment
Essent Group's business quality ultimately falls short of our standards. With its shares trailing the market in recent months, the stock trades at 0.9× forward P/B (or $56.54 per share). This valuation multiple is fair, but we don't have much faith in the company. We're fairly confident there are better stocks to buy right now. Let us point you toward a top digital advertising platform riding the creator economy.
High-Quality Stocks for All Market Conditions
Donald Trump's April 2024 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don't miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
25 minutes ago
- Washington Post
South Korean President Lee will travel to Washington for Aug. 25 meeting with Trump
SEOUL, South Korea — South Korea's new President Lee Jae Myung will travel to Washington later this month to meet with U.S. President Donald Trump, Lee's office said Tuesday, for talks on trade and defense cooperation in the face of nuclear-armed North Korea and other threats. Their Aug. 25 summit will follow a July trade deal in which Washington agreed to cut its reciprocal tariff on South Korea to 15% from the initially proposed 25% and to apply the same reduced rate to South Korean cars, the country's top export to the United States.
Yahoo
an hour ago
- Yahoo
South Korean President Lee will travel to Washington for Aug. 25 meeting with Trump
SEOUL, South Korea (AP) — South Korea's new President Lee Jae Myung will travel to Washington later this month to meet with U.S. President Donald Trump, Lee's office said Tuesday, for talks on trade and defense cooperation in the face of nuclear-armed North Korea and other threats. Their Aug. 25 summit will follow a July trade deal in which Washington agreed to cut its reciprocal tariff on South Korea to 15% from the initially proposed 25% and to apply the same reduced rate to South Korean cars, the country's top export to the United States. South Korea also agreed to purchase $100 billion in U.S. energy and invest $350 billion in the country, and the leaders could use their meeting to discuss expanding cooperation in key industries such as semiconductors, batteries and shipbuilding, Lee's spokesperson Kang Yu-jung said. The meeting also comes amid concerns in Seoul that the Trump administration could shake up the decades-old alliance by demanding higher payments for the U.S. troop presence in South Korea and possibly move to reduce it as Washington shifts more focus on China. Lee and Trump will discuss strengthening the allies' defense posture against growing North Korean threats, and also developing the partnership into a 'future-oriented, comprehensive strategic alliance' to address the changing international security and economic environment, according to Kang, who didn't elaborate on the specific issues to be addressed. Dating back to his first term, Trump has regularly called for South Korea to pay more for the 28,500 American troops stationed on its soil. Recent comments by key Trump administration officials, including Undersecretary of Defense Elbridge Colby, have also suggested a desire to restructure the alliance, which some experts say could potentially affect the size and role of U.S. forces in South Korea. Under this approach, South Korea would take a greater role in countering North Korean threats while U.S. forces focus more on China, possibly leaving Seoul to face reduced benefits but increased costs and risks, experts say. The Associated Press Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
Trump's trade war with China in 2025
By Liz Lee and Shi Bu BEIJING (Reuters) -U.S. President Donald Trump has targeted top economic rival China with a cascade of tariff orders on billions of dollars of imported goods aimed at narrowing a wide trade deficit, bringing back lost manufacturing and crippling the fentanyl trade. The timeline below shows the development of the U.S.-China trade war this year: January 21 - A day after taking office, Trump threatens 10% punitive duty on Chinese imports, citing fentanyl flowing from China. February 1 - Trump imposes 10% on goods from China along with 25% on Mexico and Canada, demanding they curb the flow of fentanyl and illegal immigrants into the U.S. February 4 - China responds with a wide range of measures targeting U.S. businesses including Google, farm equipment makers and the owner of fashion brand Calvin Klein. Beijing also slaps levies of 15% on imports of U.S. coal and LNG and 10% for crude oil and some autos, beginning February 10. It also restricted exports of five metals used in defence, clean energy and other industries. March 3 - The U.S. doubles fentanyl-related tariffs on all Chinese imports, increasing levies to 20%, effective March 4. March 4 - China hits back with 10-15% retaliatory levies on U.S. agriculture exports, affecting about $21 billion in U.S. exports. Beijing also imposed export and investment curbs on 25 U.S. firms, on grounds of national security and banned imports of genetic sequencers from U.S. medical equipment maker Illumina. April 2 - Trump escalates global trade friction with sweeping "liberation day" tariffs, announcing a baseline 10% across all imports and significantly higher duties on some countries. Trump levies 34% on all Chinese goods, to take effect on April 9. The Trump administration also decides to end duty-free access for low-value shipments from China and Hong Kong, known as "de minimis" exemptions, from May 2. April 4 - China announces retaliatory tariffs of 34% on all U.S. imports from April 10 and export curbs on some rare earths. It imposed restrictions on about 30 U.S. organisations, mostly in defence-related industries. Beijing also suspends sorghum, poultry and bone meal shipments from some U.S. firms. April 8 - The U.S. raises tariff on all Chinese imports to 84% from 34%. April 9 - China raises its levies on U.S. imports to 84% too, and added 12 U.S. companies to a control list that prohibits exports of dual-use items and another six to its "unreliable entities" list, which allows Beijing to take punitive actions against foreign entities. The U.S. further hikes tariffs on Chinese imports to 125% from 84%. China later on the day issued risk warnings to its citizens against travelling to the U.S. April 10 - China announces it would immediately restrict imports of Hollywood films. April 11 - China also raises levies on imports of U.S. goods to 125%, dismissing the Trump tariff strategy as "a joke" and indicated it will ignore any further U.S. "numbers game with tariffs". April 15 - U.S. chipmaker Nvidia discloses that U.S. officials had informed it that its H20 chip would require an export license for sales to China. May 10-12 - Beijing and Washington hold high-stakes trade talks over the weekend in Geneva. Both sides released a joint statement agreeing to a 90-day pause on their steep tariffs. The temporary truce meant U.S. tariffs on China will fall to 30% from 145%, while China tariffs on the U.S. drop to 10% from 125%. China also committed to removing non-tariff countermeasures imposed against the United States since April 2. May 28-29 - U.S. says will start "aggressively" revoking visas of Chinese students. It also orders a broad swathe of companies to stop shipping goods covering semiconductors, design software and aviation equipment to China. May 31 - Trump says China violated the agreement reached in Geneva to mutually roll back tariffs and ease Chinese curbs on critical minerals exports. China rejects the accusation, saying U.S. had introduced multiple "discriminatory restrictive" measures against China. June 5 - Chinese President Xi Jinping and Trump hold an hour-long phone call. June 9-10 - U.S. and China hold a new round of trade talks in London and reach a framework agreement. June 11-12 - Some Chinese rare earths magnet producers begin to receive export licences. Trump says trade truce is back on track. June 27 - Treasury Secretary Scott Bessent says U.S. and China have resolved issues around rare earth minerals and magnets shipments to U.S. July 6 - Trump threatens an additional 10% tariff on countries he said were aligning themselves with the "Anti-American policies" of BRICS, which includes China. July 15 - U.S. Commerce Secretary Howard Lutnick says Nvidia plans to resume sales of its advanced AI H20 chips to China is part of U.S. negotiations on rare earths, reversing a U.S. export ban in April. July 28-29 - U.S. and Chinese officials agree to seek an extension of their 90-day tariff truce after two days of talks in Stockholm. Both sides described the talks as constructive, but no major breakthroughs were announced. August 1 - Bessent says believed that Washington has the makings of a deal with China and that he is "optimistic" about the path forward. August 8 - U.S. starts issuing licenses to Nvidia to export its H20 chips to China. August 10 - Trump urges China to quadruple its soybean purchases from the U.S. as the expiration of the trade truce looms on August 12. August 11 - U.S. and China extend their tariff truce for another 90 days. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
